Enveric Biosciences (ENVB)
NASDAQ:ENVB
Holding ENVB?
Track your performance easily

Enveric Biosciences (ENVB) Stock Forecast & Price Target

448 Followers
See the Price Targets and Ratings of:

ENVB Analyst Ratings

Currently, no data available
Based on 0 analysts giving stock ratings to
Enveric
Biosciences
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ENVB Stock 12 Month Forecast

There Are No Analyst Ratings for ENVB In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

ENVB Financial Forecast

ENVB Earnings Forecast

Next quarter’s earnings estimate for ENVB is -$0.52 with a range of -$0.52 to -$0.52. The previous quarter’s EPS was -$0.23. ENVB beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 56.93% of the time in the same period. In the last calendar year ENVB has Outperformed its overall industry.
Next quarter’s earnings estimate for ENVB is -$0.52 with a range of -$0.52 to -$0.52. The previous quarter’s EPS was -$0.23. ENVB beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 56.93% of the time in the same period. In the last calendar year ENVB has Outperformed its overall industry.
No data currently available

ENVB Sales Forecast

Next quarter’s sales forecast for ENVB is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. ENVB beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.21% of the time in the same period. In the last calendar year ENVB has Underperformed its overall industry.
Next quarter’s sales forecast for ENVB is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. ENVB beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.21% of the time in the same period. In the last calendar year ENVB has Underperformed its overall industry.

Detailed List of Analyst Forecasts​

Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright
$10
Buy
2018.64%
Upside
Initiated
01/30/24
Analysts' Top Healthcare Picks: Cidara Therapeutics (CDTX), Enveric Biosciences (ENVB)

Best Analysts Covering Enveric Biosciences

Which Analyst Should I Follow If I Want to Buy ENVB and Sell After:
1 Month
xxx
Success Rate
1/1 ratings generated profit
100%
Average Return
+81.20%
initiated a xxx
rating 10 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 100.00% of your transactions generating a profit, with an average return of +81.20% per trade.
3 Months
xxx
Success Rate
1/1 ratings generated profit
100%
Average Return
+17.50%
initiated a xxx
rating 10 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +17.50% per trade.
1 Year
Vernon BernardinoH.C. Wainwright
Success Rate
0/1 ratings generated profit
0%
Average Return
-41.00%
initiated a buy rating 10 months ago
Copying Vernon Bernardino's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -41.00% per trade.
2 Years
xxx
Success Rate
0/1 ratings generated profit
0%
Average Return
-41.00%
initiated a xxx
rating 10 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -41.00% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ENVB Analyst Recommendation Trends

Rating
Mar 22
May 22
Jun 22
Nov 22
Jan 24
Strong Buy
2
2
2
3
3
Buy
0
0
0
0
0
Hold
1
1
1
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
3
3
3
3
3
In the current month, ENVB has received 3 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. ENVB average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

ENVB Stock Forecast FAQ

What is ENVB’s average 12-month price target, according to analysts?
Currently, no data Available
What is ENVB’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for ENVB, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is ENVB a Buy, Sell or Hold?
      Currently, no data Available
      What is Enveric Biosciences’s price target?
      Currently, no data Available
      What do analysts say about Enveric Biosciences?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of ENVB?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis